According to the prevailing "clock" model, chromosome decondensation and nuclear envelope reassembly during mitotic exit are byproducts of Cdk1 inactivation at the metaphase-anaphase transition, controlled by the spindle assembly checkpoint. However, mitotic exit was recently shown to be a function of chromosome separation during anaphase, assisted by a midzone Aurora B phosphorylation gradient -the "ruler" model. Here we reconciled both models by showing that Cyclin B1 degradation continues during anaphase in Drosophila, mouse and human cells, including primary tissues. This required APC/C Cdh1 activity, and failure to degrade Cyclin B1 during anaphase prevented mitotic exit in a Cdk1-dependent manner. Cyclin B1 localization and half-life during anaphase depended on kinesin-6, which targets Aurora B to the spindle midzone.
Introduction
The decision to enter and exit mitosis is critical for genome stability and the control of tissue homeostasis, perturbation of which has been linked to cancer (Evan and Vousden, 2001; Hanahan and Weinberg, 2011) . While the key universal principles that drive eukaryotic cells into mitosis are well established (Domingo-Sananes et al., 2011; Lindqvist et al., 2009; Rieder, 2011) , the mechanistic framework that determines mitotic exit remains ill-defined. The prevailing "clock" model conceives that mitotic exit results from APC/C Cdc20 -mediated Cyclin B1 degradation as cells enter anaphase, under control of the spindle assembly checkpoint (SAC) (Musacchio, 2015) . This allows the dephosphorylation of Cdk1 substrates by PP1/PP2A phosphatases, setting the time for chromosome decondensation and nuclear envelope reformation (NER) (Wurzenberger and Gerlich, 2011) , two hallmarks of mitotic exit. This model is supported by the observation that inhibition of PP1/PP2A or expression of nondegradable Cyclin B1 (and B3 in Drosophila) mutants arrested cells in anaphase Parry and O'Farrell, 2001; Schmitz et al., 2010; Sigrist et al., 1995; Vagnarelli et al., 2011; Wheatley et al., 1997; Wolf et al., 2006) . However, because Cyclin B1 is normally degraded at the metaphase-anaphase transition (Clute and Pines, 1999; Huang and Raff, 1999) , the data from non-degradable Cyclin B1 expression could be interpreted as a spurious gain of function due to the artificially high levels of Cyclin B1 that preserve Cdk1 activity during anaphase. Whether Cyclin B1/Cdk1 normally plays a role in the control of anaphase duration and mitotic exit remains unknown.
We have recently uncovered a spatial control mechanism that operates after SAC satisfaction to delay chromosome decondensation and NER in response to incompletely separated chromosomes during anaphase in Drosophila and human cells Maiato et al., 2014) . The central player in this mechanism is a constitutive midzone-based Aurora B phosphorylation gradient that monitors the position of chromosomes along the spindle axis during anaphase Maiato et al., 2014) . Thus, mitotic exit in metazoans cannot simply be explained by a "clock" that starts ticking at the metaphase-anaphase transition, but must also respond to spatial cues as cells progress through anaphase. The main conceptual implication of this "ruler" model is that mitotic exit is determined during anaphase, and not at the metaphase-anaphase transition under SAC control. In this case, a molecular "ruler" that prevents precocious chromosome decondensation and NER would allow that all separated sister chromatids end up in two individualized daughter nuclei during a normal mitosis. Moreover, it provides an opportunity for the correction and reintegration of lagging chromosomes that may arise due to deficient interchromosomal compaction in anaphase (Fonseca et al., 2019) or erroneous kinetochore-microtubule attachments that are "invisible" to the SAC (e.g. merotelic attachments) (Gregan et al., 2011) . Interestingly, Aurora B association with the spindle midzone depends on the kinesin-6/Mklp2/Subito (Cesario et al., 2006; Gruneberg et al., 2004) and is negatively regulated by Cdk1 (Hummer and Mayer, 2009 ). Thus, the establishment of a midzone-based Aurora B "ruler" in anaphase is determined by the sudden drop of Cdk1 activity (the "clock") at the metaphase-anaphase transition. In the present work we investigate whether and how molecular "rulers" also regulate the "clocks" during anaphase to coordinate mitotic exit in space and time in metazoans.
Results

Cyclin B1 continues to be degraded during anaphase and its disappearance is a strong predictor of mitotic exit in metazoans
To investigate a possible role of Cdk1 during anaphase, we started by monitoring Cyclin B1-GFP by spinning-disc confocal microscopy in live Drosophila and human cells in culture. Mild induction of Cyclin B1-GFP expression in S2 cells reproduced the localization of endogenous Cyclin B1 in the cytoplasm, mitotic spindle, kinetochores and centrosomes (Bentley et al., 2007; Clute and Pines, 1999; Huang and Raff, 1999; Pines and Hunter, 1991) , without altering normal anaphase duration or increasing chromosome missegregation ( Figure 1a and
Figure 1 -figure supplement 1a, a' and figure supplement 2a, e, f). In agreement with previous reports (Clute and Pines, 1999; Huang and Raff, 1999) , cytoplasmic Cyclin B1-GFP levels decreased abruptly at the metaphase-anaphase transition.
However, in contrast to what has been observed in Drosophila embryos (Huang and Raff, 1999) , the centrosomal pool of Cyclin B1 in S2 cells was the most resistant to degradation and persisted well after anaphase onset, becoming To extend the significance of these observations, we monitored endogenously tagged Cyclin B1-Venus levels in human HeLa and hTERT-RPE1 cells (Collin et al., 2013) its disappearance is a strong predictor of mitotic exit.
Cyclin B1 degradation and Cdk1 inactivation during anaphase are rate limiting for mitotic exit
To investigate the functional relevance of an anaphase Cyclin B1 pool we acutely inhibited Cdk1 activity at anaphase onset and found that it accelerated NER in S2 cells (Figure 2a-d) . In contrast, expression of non-degradable Cyclin B1 induced a delay in anaphase for several hours, as shown previously in human cells and Drosophila embryos Parry and O'Farrell, 2001; Potapova et al., 2006; Sigrist et al., 1995; Wolf et al., 2006) , and this delay was for degradation through recognition of a D-box, under control of the SAC (Glotzer et al., 1991) . This promotes APC/C binding to Cdh1 (APC/C Cdh1 ), which recognizes substrates with either a D-box or a KEN-box (Lindon, 2008) .
Sequence analysis of Drosophila Cyclin B1 revealed a KEN box at position 248, which we mutated to AAN (Figure 5a Cyclin B1 (Ma et al., 2012; Meghini et al., 2016) . To directly test this hypothesis, we performed RNAi against the Drosophila Cdh1 orthologue Fizzy-related (Fzr).
As in the case of the KEN-box mutant, Fzr RNAi significantly delayed Cyclin B1 degradation during anaphase, postponing mitotic exit (Figure 5e -j).
Although human Cyclin B1 lacks a canonical KEN-box, its recognition by APC/C Cdh1 might involve a D-box or other motifs, whose inactivation compromises Cyclin B1 degradation in anaphase (Clijsters et al., 2014; Lindon, 2008; Matsusaka et al., 2014) . To test the involvement of APC/C Cdh1 in the degradation of human Cyclin B1 during anaphase, we acutely inhibited APC/C activity at anaphase onset with Apcin and pro-TAME (Sackton et al., 2014; Zeng et al., 2010) in hTERT-RPE1 cells expressing endogenously tagged Cyclin B1-Venus.
This blocked the continuous degradation of Cyclin B1 during anaphase and prevented mitotic exit for several hours, similar to proteasome inhibition ( Figure 6c -f). Because pro-TAME preferentially suppresses APC/C Cdc20 (Zeng et al., 2010; Zhang et al., 2016) and only the simultaneous addition of both drugs at anaphase onset prevented mitotic exit (Figure 6c- 
Discussion
Taken together, our work reveals that Cyclin B1 degradation specifically during anaphase is rate-limiting for mitotic exit among animals that have diverged more than 900 million years ago. Most importantly, we show that Cyclin B1 homeostasis during anaphase relies on both Aurora B-mediated phosphorylation and localization at the spindle midzone. In concert with previous work , our findings unveil an unexpected crosstalk between molecular "rulers" inactivation promotes the recruitment of PP1 phosphatase to chromosomes to locally oppose Aurora B phosphorylation (Qian et al., 2015) and recent findings in budding yeast demonstrating equivalent phosphorylation and dephosphorylation events during mitotic exit (Touati et al., 2018) . Moreover, it provides an explanation for the coordinated action of two unrelated protein kinases that likely regulate multiple substrates required for mitotic exit (Afonso et al., 2017; Kettenbach et al., 2011; Petrone et al., 2016) .
Previous landmark work has carefully monitored the kinetics of Cyclin B1 degradation in living human and Ptk1 cells during mitosis, and found that Cyclin B1 was degraded by the end of metaphase, becoming essentially undetectable as cells entered anaphase (Clute and Pines, 1999) . However, we noticed that, consistent with our findings, a small pool of Cyclin B1 continued to be degraded during anaphase in Ptk1 cells (Clute and Pines, 1999) . Subsequent analysis with a FRET biosensor in human HeLa cells also revealed residual Cdk1 activity during anaphase (Gavet and Pines, 2010) , but the significance for the control of anaphase duration and mitotic exit was not investigated in these original studies.
Previous works also clearly demonstrated that forcing Cdk1 activity during anaphase through expression of non-degradable Cyclin B1 prevents chromosome decondensation and NER (Parry and O'Farrell, 2001; Wheatley et al., 1997; Wolf et al., 2006) . However, while these works suggested the existence of different Cyclin B1 thresholds that regulate distinct mitotic transitions, expression of non-degradable Cyclin B1 could be interpreted as an artificial gain of function that preserves Cdk1 activity during anaphase. For example, it was
shown that expression of non-degradable Cyclin B1 during anaphase "reactivates" the SAC, inhibiting APC/C Cdc20 (Clijsters et al., 2014; Rattani et al., 2014; Vazquez-Novelle et al., 2014) . Our work demonstrates in five different experimental systems, from flies to humans, including primary tissues, that Cyclin B1/Cdk1 is rate-limiting for the control of anaphase duration and mitotic exit.
Failure to degrade Cyclin B1/Cdk1 during anaphase blocked cells in an anaphase-like state with condensed chromosomes for several hours, whereas complete Cdk1 inactivation in anaphase was required to trigger chromosome decondensation and NER. Importantly, if a positive feedback loop imposed by phosphatases was sufficient to drive mitotic exit simply by reverting the effect of Cdk1 phosphorylation prior to anaphase, cells would exit mitosis regardless of the remaining Cyclin B1 pool that sustains Cdk1 activity during anaphase. The main conceptual implication of these findings is that, contrary to what was previously assumed, mitotic exit is determined during anaphase and not at the metaphase-anaphase transition under SAC control.
Our findings suggest that degradation of Cyclin B1 in anaphase is mediated, at least in part, by APC/C Cdh1 activity. Substrate specificity for Cdh1 is thought to be exclusively provided by the presence of a KEN box (Pfleger and Kirschner, 2000) , which is present in Drosophila Cyclin B1. Mutation of the KEN box or Cdh1 depletion by RNAi in Drosophila S2 cells compromised Cyclin B1 degradation after anaphase onset, with a consequent extension of anaphase and delay in mitotic exit. Noteworthy, human Cyclin B1 lacks a canonical KEN box, but this does not imply that it cannot be degraded by APC
Cdh1
. Indeed, there are several Lysine residues in human Cyclin B1 that might compensate the lack of a canonical KEN box and might well work as a substrate recognition signal for APC/C Cdh1 during anaphase (Clijsters et al., 2014) . Importantly, APC Cdh1 can still recognize Cyclin B1 through its D-box (Fang et al., 1998) Apcin (Sackton et al., 2014) and Pro-TAME (Zeng et al., 2010) in human hTERT-RPE1 cells expressing endogenously tagged Cyclin B1-Venus also prevented mitotic exit. Because Pro-TAME preferentially suppresses APC/C Cdc20 (Zhang et al., 2016) and only the simultaneous addition of both drugs at anaphase onset prevented mitotic exit, these results suggest that degradation of Cyclin B1 during anaphase in human cells is also mediated, at least in part, by APC/C Cdh1 .
Our model also implies that residual Cyclin B1/Cdk1 in anaphase is spatially regulated by a midzone Aurora B gradient. Indeed, due to their favourable flat morphology, we were able to identify a small pool of Cyclin B1
enriched at the spindle midzone/midbody in Drosophila S2 cells and this localization was dependent on kinesin-6-mediated recruitment of Aurora B to the spindle midzone. Interestingly, human Cyclin B2, which contains a recognizable KEN box, localizes at the midbody and Cdk1 inactivation during late mitosis was required for the timely completion of cytokinesis in human cells (Mathieu et al., 2013 ). Thus, it is possible that in human cells, Cdk1 activity during anaphase is regulated not only by Cyclin B1, but also by Cyclin B2, likely mediated by APC/C Cdh1 . This model predicts the existence of a midzone-centred Cdk1 activity gradient during anaphase, but so far, we have been unsuccessful in our attempts to target FRET reporters of Cdk1 activity (Gavet and Pines, 2010) Zhang et al., 2016 ).
In conclusion, we uncovered an unexpected level of regulation at the end of mitosis and reconciled what were thought to be antagonistic models of mitotic exit relying either on molecular "clocks" or on "rulers". These findings have profound implications to our fundamental understanding of how tissue homeostasis is regulated, perturbation of which is a hallmark of human cancers. 
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Figure 6. Proteasome and APC/C inhibition at anaphase onset induces an anaphase arrest in human hTERT-RPE1 cells. (a)
Control hTERT-RPE1 cell expressing endogenous Cyclin B1-Venus and co-stained with SiR-DNA to visualize mitotic chromosomes. (b) MG132 addition just before or at anaphase onset (time 00:00), caused an anaphase arrest with detectable Cyclin B1 levels and condensed chromosomes. The arrest was sustained up to 6h (time window of acquisition). (c) pro-TAME addition at anaphase onset (time 00:00) showed no visible effect during anaphase. (d) Apcin addition at anaphase onset (time 00:00) induced a slight delay in DNA decondensation. (e) APC/C inhibition with a cocktail of pro-TAME and Apcin at anaphase onset (time 00:00) caused a strong anaphase delay (during the time window of acquisition -5 hours). Cyclin B1 localization is highlighted with LUT "fire". Scale bars are 5 μm. Time is in h:min. (f) Quantification of Cyclin B1-Venus (normalized to anaphase onset) in control (n=7 cells), MG132 (n=4 cells), pro-TAME (n=7 cells), Apcin (n=6 cells) and pro-TAME+Apcin (n=4 cells). 
Methods
Cell culture
Drosophila S2 cells were cultured in Schneider medium supplemented with 10% FBS and grown at 25ºC. For live imaging cells were plated 2-3 h before imaging in MatTek dishes (MatTek Corporation) pre-coated with 0.25 mg/ml concanavalin A. Human U2OS and HeLa cells were cultured in DMEM supplemented with 10% FBS and grown in a 5% CO 2 atmosphere at 37°C. hTERT-RPE1 cells were grown in DMEM/F12 medium supplemented with 10% FBS. For all human cell lines culture medium was changed to L-15 supplemented with 10% FBS 4-5 h before live imaging.
Drug treatments
For acute inhibition of Cdk1 in S2 and U2OS cells the Cdk1 inhibitor RO3306 (Sigma) was added in metaphase or at anaphase onset, depending on the experimental set-up, at final concentration of 10 μM. Binucleine-2 (Sigma) was used to acutely inhibit Aurora B activity in Drosophila S2 cells at a final concentration of 40 μM in all experiments. For the live MG132 assay in Drosophila S2 cells, metaphase cells grown in the absence of the drug were selected in a multipoint set-up and MG132 was added after the first round of acquisition (5 min), at a final concentration of 20 μM. Cells that entered anaphase in a time window between 30-60 min after drug addition became arrested in anaphase, while the remaining cells became arrested in metaphase. MG132 addition at anaphase onset had no effect on the anaphase-telophase transition, likely due to a slow uptake of the drug in S2 cells. For the MG132 assay in U2OS and hTERT-RPE1 cells, MG132 was added 1-2 min before or at anaphase onset also at a final concentration of 20 μM. Drug addition 1-2 min after anaphase onset in U2OS or hTERT-RPE1 cells had no effect on anaphase duration. APC/C inhibition at anaphase onset on hTERT-RPE1 cells was achieved with a combination of both pro-TAME (Boston Biochem) and Apcin (Tocris Bioscience) used at final concentrations of 6.3 μM and 200 μM, respectively, as previously reported (Sackton et al., 2014) . Similarly to MG132 treatment, APC/C inhibition 1-2 min after anaphase onset, or individual treatment with each drug showed a mild or no effect. ZM447439 (Tocris Bioscience) was used at 4 μM in all experiments to inhibit Aurora B in human cells. SiR-DNA (Spirochrome) was used at a final concentration of 80 nM in Drosophila S2 cells and 50 nM in hTERT-RPE1 cells and incubated 30-60 min prior to imaging.
Immunofluorescence microscopy Drosophila S2 cells were grown in coverslips previously pre-coated with 0.25 mg/ml concanavalin A. hTERT-RPE1 control and Mklp2-depleted cells were plated on glass coverslips. Cells were fixed with 4% PFA for 10 minutes, permeabilized with 0.3% Triton diluted in PBS for 10 min and washed 3x5 min with PBS-Tween. Primary antibodies used were mouse anti-α-tubulin (1:2000; B-512 clone, Sigma); rabbit anti-Cyclin B1 (gift from James Wakefield, University of Exeter); mouse anti-Aurora B (1:500, Aim1, BD Biosciences) and rabbit anti-Cenp C (gift from Claudio Sunkel, i3S, University of Porto, Portugal). Corresponding Alexa-Fluor secondary antibodies were used at 1:2000. Fixed images from Figure 1 -figure supplement 1 were obtained on an inverted Zeiss 780 confocal microscope with a 63x oil immersion objective. Fixed images from Figure 1 -figure supplement 3e and f were obtained on an AxioImager Z1 with a 63x, plan oil differential interference contrast objective lens, 1.4 NA (from Carl Zeiss), equipped with a charge-coupled device (CCD) camera (ORCA-R2; Hamamatsu Photonics).
Constructs
The pMT-GFP-Aurora B and the non-degradable Cyclin B1-GFP were described previously . The WT-, 5A-and 5E-Cyclin B1 pENTR constructs were a kind gift from Jean-René Huynh (Institute Curie, France). For expression in Drosophila S2 cells WT-, 5A-and 5E-Cyclin B1 constructs were cloned in a pMT-W-GFP destination vector (gift from Eric Griffis, University of Dundee, UK) using the LR clonase reaction from the Gateway system (Invitrogen). The KEN-box mutant was generated in the pMT-Cyclin B1-GFP plasmid using a site-directed mutagenesis kit (Agilent), following the manufacturer instructions. The following primers were used for mutagenesis:
Fw: 5'-GGACATTGATGCCAATGACGCGGCGAACCTGGTACTGGTCTCC-3' and Rv 5'-GGAGACCAGTACCAGGTTCGCCGCGTCATTGGCATCAATGTCC-3'.
Cell lines, transfections and RNAi The H2B-GFP/mCherry-α-tubulin and Lamin B-GFP/mCherry-α-tubulin stable cell lines have been previously described . The WT-Cyclin B1-GFP/mCherry-α-tubulin, KEN-Cyclin B1-GFP/mCherry-α-tubulin and GFP-Aurora B/WT-Cyclin B1-mCherry stable cell lines were established using Effectene (Qiagen) according to the manufacturer instructions. For visualization of WT-Cyclin B1-GFP, WT-Cyclin B1-mCherry and GFP-Aurora B signals 250 μM of CuSO4 was added to the medium overnight (8-12 h) to induce expression from a metallothionein promoter. With this copper concentration, we obtained a mild expression of the constructs without any detectable impact on mitotic progression. Aurora B overexpression was achieved by adding 1 mM of CuSO4 instead of 250 μM for the same incubation period. For the analysis of the Cyclin B1 phosphorylation mutants, transient transfections on a H2B-GFP/mCherry-α-tubulin stable cell line were performed using Effectene (Quiagen) according to the manufacturer instructions and overexpression was induced with 500 μM of CuSO4 incubated overnight in the cell culture medium. The HeLa and hTERT-RPE1 Cyclin B1-Venus cell lines (Collin et al., 2013) were a kind gift from Jonathon Pines (Institute of Cancer Research, UK). The H2B-mRFP expression construct for human cells was obtained from Addgene (#26001), transfected to 293T cells to produce viruses and infect HeLa Cyclin B1-Venus expressing cells to generate a stable cell line. The H2B-GFP/mCherry-α-tubulin U2OS cell line and the Subito/Mklp2 RNAi in Drosophila S2 cells were previously described . Fzr RNAi in Drosophila S2 cells was achieved after two rounds of RNAi treatment for a total of 7 days. The following primers were used for dsRNA synthesis: 5'-TAATACGACTCACTATAGGGCACCGGATAATCAATACTTGGC-3' and 5'-TAATACGACTCACTATAGGGATTCAGAACGGACTTGTTCTCC-3'. Mklp2 depletion in hTERT-RPE1 cells was achieved 72 h after transfection of siRNA oligonucleotides using Lipofectamine RNAiMAX (Invitrogen) following the manufacturer instructions. The oligonucleotide sequence used was: 5'-AACGAACUGCUUUAUGACCUA-3'.
Time-lapse microscopy Live imaging data in figures 2 and 9 and figure 2 -figure supplement 1 were obtained from a spinning disc confocal system (Andor Technology, South Windsor, CT) equipped with an electron multiplying CCD iXonEM+ camera and a Yokogawa CSU-22 U (Yokogawa Electric, Tokyo) unit based on an Olympus IX81 inverted microscope (Melville, NY). Two laser lines (488 and 561 nm) were used for near simultaneous excitation of GFP and mCherry/mRFP and the system was driven by Andor IQ software. Time-lapse image stacks of 0.8 μm steps were collected every 30 sec, with a Plan-APO 100x/1.4 NA oil objective, with the exception of the experiments in figure 2 -figure supplement 1 where image stacks were obtained every 60 sec. Live imaging data in figures 1, 3, 4, 5a-h, 6-8, figure 1 -figure supplement 2 and 3a-d and figure 7 -figure supplement 1 and 2 were acquired in a temperature-controlled Nikon TE2000 or a Ti microscope, both equipped with a Yokogawa CSU-X1 spinning-disc head, imaged on an Andor iXon+ DU-897E EM-CCD. Excitation comprises three lasers (488nm, 561nm and 647nm) that were shuttered by an acousto-optic tunable filter (TE2000) or electronically (Ti). Sample position was controlled via a SCAN-IM Marzhauser stage and a Physik Instrumente 541.ZSL piezo (TE2000) or via a Prior Scientific ProScan stage (Ti). Imaging of Drosophila S2 cells was performed with a 100x Plan-Apo DIC CFI Nikon objective in all experiments. Imaging of human cells and the Drosophila follicular epithelium was done with an oilimmersion 60x 1.4 NA Plan-Apo DIC CFI (Nikon, VC series). Imaging of the mouse oocytes was performed either with a 60x 1.27 NA CFI Plan-Apo IR water-immersion objective (Nikon) or a 40x 1.30 NA Plan-Fluor oil-immersion objective (Nikon). Images were acquired with a 1 µm z-stack and 30 sec time-lapse interval for all live imaging experiments in Drosophila S2 cells, Drosophila follicular epithelium and human cells. Mouse oocytes were acquired with a 4 µm z-stack and a 2 min time interval. Data from figures 3 and 6 were obtained with a 5 min time interval and data from figure 4 were obtained with a 1min time interval. A temperature-controlled chamber was set up to 25ºC for Drosophila live imaging or to 37ºC for live imaging of human cells and mouse oocytes.
SiR-DNA (Spirochrome) was used at a final concentration of 80 nM in Drosophila S2 cells or 50 nM in hTERT-RPE1 cells and incubated 30-60 min prior to imaging.
Drosophila strains and egg chamber preparation Flies homozygous for the eGFP protein trap insertion into CycB1 loci (CC01846 (Buszczak et al., 2007) ) and expressing His2Av-mRFP (genotype: w ; P{PTT-GC}CycB CC01846 ; P{His2Av-mRFP}/+) were generated to image Cyclin B1 expression at endogenous levels while monitoring mitotic progression. Drosophila egg chambers were dissected and mounted in the gas-permeable oil 10S VOLTALEF® (VWR chemicals) for live imaging.
In vitro culture and micro-injection of mouse oocytes All mice were maintained in a specific pathogen-free environment according to the Portuguese animal welfare authority (Direcção Geral de Alimentação e Veterinária) regulations and the guidelines of the Instituto de Investigação e Inovação em Saúde animal facility. Oocytes were isolated from ovaries of 7-10 week old CD-1 mice, cultured in M2 medium under mineral oil and matured to metaphase II in vitro for 16 hours at 37ºC. Oocytes were then microinjected with mRNA encoding Cyclin B1-mCherry using an electric-assisted microinjection system (FitzHarris et al., 2018) . A function generator (GW Instek AFG-2005) was used to produce electrical current instead of an intracellular electrometer. Oocytes were then transferred to M2 medium supplemented with SiR-DNA (500 nM, Spirochrome) and allowed to express the mRNA for 4-6 hours. Oocytes were then induced parthenogenically by rinsing into calcium-free M2 medium with 10 mM strontium chloride, and imaged.
mRNA in vitro transcription pGEMHE-CyclinB1-mCherry was a kind gift from Melina Schuh (Max-Planck Institute for Biophysical Chemistry). The plasmid was linearised, and capped mRNA was synthesised using the T7 ARCA mRNA kit (New England Biolabs) according to the user's manual and resuspended in water. The final concentration of mRNA in the injection needle was 400 ng/µl. Definition of mitotic exit Mitotic exit was defined either by the moment of NER or chromosome decondensation. When a nuclear envelope marker was present (ex: Lamin B in figure 2) mitotic exit was defined as the first frame of appearance of Lamin B in the nascent nucleus. In experiments where cells expressed mCherry-α-tubulin, NER was determined based on the first frame where soluble mCherry-α-tubulin was excluded from the main nucleus. In those cases where mCherry-α-tubulin was not present, SiR-DNA was used instead and visual inspection of DNA decondensation was used to define mitotic exit.
Quantification of Cyclin B1 decay during anaphase Image processing and quantification was performed using Fiji. Data from Drosophila S2 in figures 3e, 5d and h, 8c, 9d and g and , figure 1 -figure supplement 2b, Cyclin B1 were measured with a constant circular ROI around the centrosomes. This resulted in more robust measurements, which were less prone to fluorescence fluctuations in the cytoplasm. This was essential to detect differences in the Cyclin B1 decay in the different conditions tested. Exceptionally, and to compare Cyclin B1 levels in Drosophila and human cells, in figure 1c total Cyclin B1-GFP fluorescence intensity was measured using an ROI defined by the limits of the cell. Cyclin B1 levels from figure 7e and figure 7 -figure supplement 2 were measured with a constant rectangular ROI defined by the size of the metaphase plate before cells entered anaphase. This size and position was maintained to measure the intensity of Cyclin B1 that localized at the spindle midzone in control cells and after Cdk1 addition. Note that with the same ROI in figure 7 -figure supplement 2 both Cyclin B1 and Aurora B intensities were measured. Data from human cells from figures 1b, 6f and Figure 1 -figure supplement 3 , total Cyclin B1 were measured with an ROI defined by the limits of the cell. In both cases, the ROI was used to manually track the centrosome/midzone/cell over time. Images were maximum intensity projected and background was measured for all time points with the same ROI used for Cyclin B1 measurements in a region outside the cell. The background levels were subtracted from the absolute intensity values. In the Drosophila follicular epithelium Cyclin B1 levels were measured in sum-intensity Z projections, using a circular ROI that was manually tracked in an homogeneous cytoplasmic region (free of accumulated Cyclin B at microtubules or centrosomes) of dividing cells. Background was measured with the equivalent ROI in G1 phase cells (identified by undetectable Cyclin B1-GFP expression) within the same egg chamber, and subtracted to dividing cells to establish the baseline background value. In mouse oocytes, Cyclin B1 was measured using a ROI placed manually into the center of the oocyte, background levels were measured in a ROI outside the cell and used for subtraction from the mean cytoplasmic intensity. Images were sum-intensity Z projected.
Calculation of Cyclin B1 half-life The half-life of Cyclin B1-GFP or Cyclin B1-Venus was calculated based on the formula * 2 ln (
) ⁄ where t is the time interval, n(0) is the background subtracted Cyclin B1-GFP fluorescent intensity at anaphase onset and n(t) is the background subtracted Cyclin B1-GFP fluorescent intensity at time 4.5 min after anaphase onset. Code Availability Matlab based custom routines were used for the generation of kymographs. Code is available from the corresponding author upon request.
Data availability All data generated or analysed during this study are included in this published article (and its supplementary information files). Raw movies are available from the corresponding author on reasonable request.
